Longevity Biotech Company

Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures.

Last Funding Type: Grant
Headquarters: United States
Founded Date: 2010
Investor Type: Company
Total Funding: $836.4K
Technology: Metabolic Disorders
Employee Number: 1-10
Number Of Exists: Grant
Estimated Revenue: Less than $1M
Investors Number: 2
Industry: Energetic Process